Last updated on November 2019
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
Brief description of study
The purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis study.
The study provides for 7 years of additional treatment with baricitinib.
Clinical Study Identifier: NCT01885078
Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )
